{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:58:32Z","timestamp":1790751512078,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.01.044","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T17:16:13Z","timestamp":1510679773000},"page":"6472-6482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"PA","title":["Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation"],"prefix":"10.1016","volume":"35","author":[{"given":"Malini","family":"DeSilva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Sell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Tse Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Kachikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Oleske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fyezah","family":"Jehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Nesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beckie N.","family":"Tagbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Cutland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda O.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azucena","family":"Bardaj\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.01.044_b0005","unstructured":"Division of Birth Defects and Developmental Disabilities N, Centers for Disease Control and Prevention. Facts about microcephaly; 2016."},{"key":"10.1016\/j.vaccine.2017.01.044_b0010","unstructured":"Organization WH. Assessment of infants with microcephaly in the context of Zika virus; 2016."},{"key":"10.1016\/j.vaccine.2017.01.044_b0015","unstructured":"National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) CfDCaP. Congenital microcephaly case definitions; 2016."},{"key":"10.1016\/j.vaccine.2017.01.044_b0020","first-page":"175","article-title":"Microcephaly: general considerations and aids to nosology","volume":"10","author":"Opitz","year":"1990","journal-title":"J Craniofac Genet Dev Biol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0025","unstructured":"Swaiman KF AS, Ferriero DM, Schor NF. Swaiman\u2019s pediatric neurology: principles and practice; 2012."},{"key":"10.1016\/j.vaccine.2017.01.044_b0030","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1542\/peds.79.5.706","article-title":"Head circumference reference data: birth to 18 years","volume":"79","author":"Roche","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.01.044_b0035","first-page":"163","article-title":"Case report of microencephalia","volume":"127","author":"Santa Cruz","year":"1983","journal-title":"Zentralbl Allg Pathol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1469-8749.1991.tb14813.x","article-title":"The predictive value of microcephaly during the first year of life for mental retardation at seven years","volume":"33","author":"Dolk","year":"1991","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)00651-6","article-title":"Association between Zika virus and microcephaly in French Polynesia, 2013\u201315: a retrospective study","author":"Cauchemez","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.01.044_b0050","unstructured":"Missouri birth defects 1995\u20131999. Missouri Department of Health and Senior Services, Jefferson City (MO) (CHIME Publications No.: 4.46); 2002."},{"key":"10.1016\/j.vaccine.2017.01.044_b0055","doi-asserted-by":"crossref","unstructured":"Network NBDP. Major birth defects data from population-based birth defects surveillance programs in the United States, 2006\u20132010. Birth Defects Res (Part A): Clin Mol Teratol 2013;97:S1\u2013S172.","DOI":"10.1002\/bdra.23198"},{"key":"10.1016\/j.vaccine.2017.01.044_b0060","unstructured":"Bhide PKA. Birth prevalence of microcephaly in India. Bull World Health Organ."},{"key":"10.1016\/j.vaccine.2017.01.044_b0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.15585\/mmwr.mm6509e2","article-title":"Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015","volume":"65","author":"de Oliveira","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.01.044_b0070","doi-asserted-by":"crossref","DOI":"10.2471\/BLT.16.170639","article-title":"Microcephaly in northeast Brazil: a review of 16 208 births between 2012 and 2015","author":"Soares de Ara\u00fajo","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.01.044_b0075","doi-asserted-by":"crossref","first-page":"917","DOI":"10.15585\/mmwr.mm6534e3","article-title":"Hearing loss in infants with microcephaly and evidence of congenital Zika Virus Infection \u2013 Brazil, November 2015-May 2016","volume":"65","author":"Leal","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.01.044_b0080","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects - reviewing the evidence for causality","author":"Rasmussen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.01.044_b0085","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/S0140-6736(16)30776-0","article-title":"Zika: neurological and ocular findings in infant without microcephaly","volume":"387","author":"Ventura","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.01.044_b0090","doi-asserted-by":"crossref","first-page":"i1901","DOI":"10.1136\/bmj.i1901","article-title":"Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study","volume":"353","author":"de Fatima Vasco Aragao","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.01.044_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1148\/radiol.2016161584","article-title":"Congenital brain abnormalities and Zika virus: what the radiologist can expect to see prenatally and postnatally","volume":"281","author":"de Oliveira-Szejnfeld","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.vaccine.2017.01.044_b0100","doi-asserted-by":"crossref","first-page":"870","DOI":"10.15585\/mmwr.mm6533e2","article-title":"Update: interim guidance for the evaluation and management of infants with possible congenital Zika Virus infection \u2013 United States, August 2016","volume":"65","author":"Russell","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.01.044_b0105","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/01.wnl.0000183747.05269.2d","article-title":"A developmental and genetic classification for malformations of cortical development","volume":"65","author":"Barkovich","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2017.01.044_b0110","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/dmcn.12425","article-title":"Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature","volume":"56","author":"von der Hagen","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.spen.2007.07.003","article-title":"Microcephaly syndromes","volume":"14","author":"Abuelo","year":"2007","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-444-52891-9.00013-0","article-title":"Microcephaly","volume":"111","author":"Passemard","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0125","unstructured":"Online Mendelian Inheritance in Man; 2016."},{"key":"10.1016\/j.vaccine.2017.01.044_b0130","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1016\/j.vaccine.2014.09.052","article-title":"Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines","volume":"32","author":"Keller-Stanislawski","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0135","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/j.vaccine.2012.04.081","article-title":"A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy","volume":"30","author":"Oppermann","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajog.2012.07.007","article-title":"Safety of MF59-adjuvanted A\/H1N1 influenza vaccine in pregnancy: a comparative cohort study","volume":"207","author":"Heikkinen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0145","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/j.1471-0528.2012.03470.x","article-title":"Vaccination against H1N1 influenza with Pandemrix during pregnancy and delivery outcome: a Swedish register study","volume":"119","author":"Kallen","year":"2012","journal-title":"BJOG: An Int J Obstetr Gynaecol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/OGX.0b013e318273e5d6","article-title":"Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy","volume":"67","author":"Pasternak","year":"2012","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.vaccine.2017.01.044_b0155","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.vaccine.2015.02.068","article-title":"Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes","volume":"33","author":"McMillan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0160","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.vaccine.2015.03.041","article-title":"A\/H1N1 pandemic influenza vaccination: a retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy","volume":"33","author":"Fabiani","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0165","doi-asserted-by":"crossref","unstructured":"Trotta F, Da Cas R, Spila S, Gramegna M, Venegoni M, Zocchetti C, et al. Evaluation of safety of A\/H1N1 pandemic vaccination during pregnancy: Cohort study. BMJ (Online) 2014;348.","DOI":"10.1136\/bmj.g3361"},{"key":"10.1016\/j.vaccine.2017.01.044_b0170","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.vaccine.2014.09.054","article-title":"Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan","volume":"32","author":"Huang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0175","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.01.044_b0180","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/j.1471-0528.2012.03470.x","article-title":"Vaccination against H1N1 influenza with Pandemrix((R)) during pregnancy and delivery outcome: a Swedish register study","volume":"119","author":"Kallen","year":"2012","journal-title":"BJOG"},{"issue":"1422\u20136","key":"10.1016\/j.vaccine.2017.01.044_b0185","first-page":"e1","article-title":"Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes","volume":"163","author":"Shakib","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2017.01.044_b0190","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0195","unstructured":"Heinonen O, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Publishing Sciences Group; 1977."},{"key":"10.1016\/j.vaccine.2017.01.044_b0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0020-7292(99)00008-9","article-title":"Tetanus toxoid and congenital abnormalities","volume":"64","author":"Czeizel","year":"1999","journal-title":"Int J Gynecol Obstetr"},{"key":"10.1016\/j.vaccine.2017.01.044_b0205","first-page":"605","article-title":"Safety of tetanus toxoid in pregnant women: a hospital-based case-control study of congenital anomalies","volume":"73","author":"Silveira","year":"1995","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.01.044_b0210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/clinids\/18.3.414","article-title":"Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome","volume":"18","author":"Harjulehto-Mervaala","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.044_b0215","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1093\/cid\/civ061","article-title":"Adverse events following measles, mumps, and rubella vaccine in adults reported to the vaccine adverse event reporting system (VAERS), 2003\u20132013","volume":"60","author":"Sukumaran","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.044_b0220","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.ogx.0000320481.20343.06","article-title":"Varicella vaccine exposure during pregnancy: data from 10 years of the pregnancy registry","volume":"63","author":"Wilson","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.vaccine.2017.01.044_b0225","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/pds.3554","article-title":"Pooled analysis of large and long-term safety data from the human papillomavirus-16\/18-AS04-adjuvanted vaccine clinical trial programme","volume":"23","author":"Angelo","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2017.01.044_b0230","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/AOG.0b013e3181c2ca21","article-title":"Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6\/11\/16\/18 vaccine: a combined analysis of five randomized controlled trials","volume":"114","author":"Garland","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0235","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1016\/j.vaccine.2015.04.014","article-title":"Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine","volume":"33","author":"Goss","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0240","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/pds.3593","article-title":"Post-licensure safety surveillance for human papillomavirus-16\/18-AS04-adjuvanted vaccine: more than 4 years of experience","volume":"23","author":"Angelo","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2017.01.044_b0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13027-015-0012-2","article-title":"Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy","volume":"10","author":"Nakalembe","year":"2015","journal-title":"Infect Agent Cancer"},{"issue":"478","key":"10.1016\/j.vaccine.2017.01.044_b0250","first-page":"e1","article-title":"Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System","volume":"208","author":"Zheteyeva","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.01.044_b0255","doi-asserted-by":"crossref","first-page":"B46","DOI":"10.1016\/j.vaccine.2011.12.112","article-title":"Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010","volume":"30","author":"Ouandaogo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0260","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2016.03.049","article-title":"Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011\u20132015","volume":"34","author":"Moro","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.03.047","article-title":"Congenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","author":"DeSilva","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0270","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1016\/j.vaccine.2007.02.063","article-title":"The development of standardized case definitions and guidelines for adverse events following immunization","volume":"25","author":"Kohl","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0275","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ajmg.c.30310","article-title":"Teratogenic exposures","volume":"157C","author":"Obican","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.vaccine.2017.01.044_b0280","unstructured":"Prevention CfDCa. Measuring head circumference. CDC\u2019s response to Zika; 2016."},{"key":"10.1016\/j.vaccine.2017.01.044_b0285","unstructured":"Organization WH. Child growth standards: head circumference-for-age; 2016."},{"key":"10.1016\/j.vaccine.2017.01.044_b0290","unstructured":"Oxford Uo. The International Fetal Standards: Head Circumference (mm)."},{"key":"10.1016\/j.vaccine.2017.01.044_b0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1471-0528.12313","article-title":"Ultrasound methodology used to construct the fetal growth standards in the INTERGROWTH-21st Project","volume":"120 Suppl 2","author":"Papageorghiou","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.vaccine.2017.01.044_b0300","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/uog.15896","article-title":"ISUOG Interim Guidance on ultrasound for Zika virus infection in pregnancy: information for healthcare professionals","volume":"47","author":"Papageorghiou","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0305","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2016.02.043","article-title":"Ultrasound screening for fetal microcephaly following Zika virus exposure","volume":"214","author":"Society for Maternal-Fetal Medicine Publications C","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.arcped.2008.10.010","article-title":"Le Comite de nutrition de la Societe francaise de p [WHO growth standards for infants and young children]","volume":"16","author":"de Onis","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.vaccine.2017.01.044_b0315","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(14)61490-2","article-title":"International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project","volume":"384","author":"Papageorghiou","year":"2014","journal-title":"Lancet"},{"issue":"449","key":"10.1016\/j.vaccine.2017.01.044_b0320","first-page":"e1","article-title":"Racial\/ethnic standards for fetal growth: the NICHD Fetal Growth Studies","volume":"213","author":"Buck Louis","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.044_b0325","unstructured":"Quinn J, Munoz FM, Gonik B, Frau L, Cutland C, Mallett-Moore T, et al. Preterm birth: case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine."},{"key":"10.1016\/j.vaccine.2017.01.044_b0330","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1016\/j.vaccine.2007.04.062","article-title":"Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Kohl","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.044_b0335","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1016\/j.vaccine.2007.04.056","article-title":"Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data","volume":"25","author":"Kohl","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:45:05Z","timestamp":1750985105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1730107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":67,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X1730107X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}